MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/eci.12895

Медицинская библиотека · European journal of clinical investigation · 2018

Survivin is a negative prognostic factor in malignant pleural effusion.

Arellano-Orden Elena, Romero-Romero Beatriz, Sánchez-López Verónica, Martín-Juan José, Rodríguez-Panadero Francisco, Otero-Candelera Remedios

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Survivin is a well-known member of the inhibitor of apoptosis family, and has been related to increased tumour aggressivity, both in tissue and in pleural fluid.

OBJECTIVES

In patients with malignant pleural effusion, we sought to investigate the changes in pleural fluid survivin concentrations induced by talc instillation into the pleural space. Those changes were also examined in relation to pleurodesis outcome and patient survival.

METHODS

We investigated 84 patients with malignant pleural effusion who underwent talc pleurodesis. Of them, 32 had breast cancer, 25 lung cancer and 27 had mesothelioma. Serial samples of pleural fluid were obtained before thoracoscopy (baseline) and 24 hours thereafter.

RESULTS

Survivin levels were successfully quantified in all pleural fluid samples, and they were significantly higher in samples obtained after thoracoscopic talc poudrage compared with baseline (P < .001). Patients with higher pleural fluid survivin levels at baseline had a significantly poorer pleurodesis outcome (P = .004). A 30 pg/mL cut-off for baseline survivin in pleural fluid predicted failure of pleurodesis with a 54% sensitivity and 79% specificity (P = .009). Moreover, median postpleurodesis survival of patients with baseline survivin levels ≥30 pg/mL was 4 months (range: 0.1-38), compared with 13 months (range: 0.1-259) in patients below that cut-off (P < .001).

CONCLUSION

Elevated pleural fluid survivin concentrations are useful to predict failure of pleurodesis and are associated with shorter survival in patients with malignant pleural effusion.

Для цитирования: Arellano-Orden Elena, Romero-Romero Beatriz, Sánchez-López Verónica, Martín-Juan José, Rodríguez-Panadero Francisco, Otero-Candelera Remedios. Survivin is a negative prognostic factor in malignant pleural effusion.. European journal of clinical investigation. 2018. DOI: 10.1111/eci.12895.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.